Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan-Reference-Cited by-同舟云学术

Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan

Published:2012-04-05 Issue:5 Volume:73 Page:776-785
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Etienne-Grimaldi Marie-Christine,Bennouna Jaafar,Formento Jean-Louis,Douillard Jean-Yves,Francoual Mireille,Hennebelle Isabelle,Chatelut Etienne,Francois Eric,Faroux Roger,El Hannani Chaza,Jacob Jacques-Henri,Milano Gérard

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2011.04141.x/fullpdf

Reference57 articles.

1. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

2. Oral Uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06;Lembersky;J Clin Oncol,2006

3. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N Engl J Med,2009

4. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer;Bokemeyer;J Clin Oncol,2009

5. The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer;Toffoli;J Clin Oncol,2006

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC;Pharmaceutics;2022-11-15

2. Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies;Frontiers in Oncology;2022-06-24

3. The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?;Journal of Personalized Medicine;2020-11-19

4. Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients;Cancers;2020-10-13

5. Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer;The Pharmacogenomics Journal;2019-10-15